Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bally's (BALY) Accumulated Expenses (2018 - 2025)

Bally's (BALY) has disclosed Accumulated Expenses for 8 consecutive years, with $665.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Expenses fell 6.49% to $665.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $665.7 million, a 6.49% decrease, with the full-year FY2024 number at $481.3 million, down 26.15% from a year prior.
  • Accumulated Expenses was $665.7 million for Q3 2025 at Bally's, down from $669.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $717.8 million in Q2 2024 to a low of $131.8 million in Q1 2021.
  • A 5-year average of $488.5 million and a median of $481.9 million in 2023 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: soared 234.37% in 2021, then decreased 26.15% in 2024.
  • Bally's' Accumulated Expenses stood at $401.4 million in 2021, then surged by 42.97% to $573.9 million in 2022, then rose by 13.55% to $651.7 million in 2023, then fell by 26.15% to $481.3 million in 2024, then surged by 38.32% to $665.7 million in 2025.
  • Per Business Quant, the three most recent readings for BALY's Accumulated Expenses are $665.7 million (Q3 2025), $669.2 million (Q2 2025), and $543.0 million (Q1 2025).